CHRO (Chromocell) Kelajakdagi narxning foydaga nisbati
Chromocell Therapeutics (CHRO) turli xil og'riq turlarini boshqarish uchun opioid bo'lmagan davolash vositalari portfelini ishlab chiqmoqda. GURU.Markets tomonidan taqdim etilgan emitentning forward P/E grafigi bozor kutganlarini tasdiqlaydi, bunda 0.00 ko'rsatkichi joriy dinamikani aks ettiradi. Rahbariyat sifatli sinovlarning nishey strategiyasiga e'tibor qaratmoqda, biroq resurslarning ion kanallariga yuqori konsentratsiyasi butun uzoq muddatli model uchun sezilarli binary zaiflikni yuzaga keltirmoqda.
Chromocell (CHRO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- biznesning bozor baholash ko'rsatkichlari:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Chromocell Therapeutics Corp|CHRO - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Chromocell Therapeutics|Tezkor likvidlik chromocell.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CHRO - Kompaniyaning sof foydasi|Kelajakdagi foyda Chromocell Therapeutics|CHRO - Kompaniya qiymatining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Chromocell Therapeutics Corporation|CHRO - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Chromocell Therapeutics Corp|CHRO - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Chromocell Therapeutics|CHRO - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi chromocell.com|CHRO - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Chromocell Therapeutics
Kompaniyaning fundamental tahlili:Chromocell Therapeutics Corp.
Uzoq muddatli rejalashtirish uchun investor Chromocell Therapeutics (CHRO) aksiyalarining qiymatini kompaniyaning konsensus P/E prognozida aks etgan joriy narxning kutilayotgan foydaga nisbatiga ko'ra baholaydi. Ushbu ko'rsatkich kelajakdagi daromadlar bo'yicha bozor kutuvlarini o'lchaydi, biomeditsina sektorining barqarorligi va uning neytral geosiyosiy maqomi esa baholashdagi tebranishlar xavfini minimallashtirib, biznesning fundamental chidamliligini tasdiqlaydi.
Chromocell Therapeutics (CHRO) raqobatchilari
Forvard P/E multiplikatori BIIB|NBIX (Neurocrine) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Regencell RGC|Kelajakdagi narx-foyda multiplikatori AXSM|ACAD - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati xenon-pharma.com|Viking Therapeutics, Inc. (VKTX) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Supernus Pharmaceuticals, Inc.|Kelajakdagi narxning foydaga nisbati Catalyst Pharmaceuticals Inc|Prognoz qilingan narx-foyda nisbati Denali Corp DNLI|Forvard P/E multiplikatori HRMY|Prognoz qilingan narxning foydaga nisbati biohavenpharma.com BHVN|Forvard P/E multiplikatori AMLX (Amylyx Pharmaceuticals, Inc.)|Trevi Therapeutics Inc (TRVI) - Prognoz qilingan narx-foyda nisbati|PRAX - Kelajakdagi narxning foydaga nisbati|AVXL: Kelajakdagi narxning foydaga nisbati|CeriBell, Inc. (CBLL) - Kelajakdagi narxning foydaga nisbati|PRTA (Prothena) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ALEC|ANNX: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati OMER (Omeros Corporation)|Kapitalizatsiyaning kelajakdagi foydaga nisbati NGNE|Forvard P/E multiplikatori ACIU (AC Immune)|Kelajakdagi narx-foyda multiplikatori VYGR|Neumora Therapeutics, Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Scilex Holding|Tevogen Bio Holdings, Inc. (TVGN) - Kelajakdagi narxning foydaga nisbati|Alpha Cognition Inc. - Kelajakdagi narx-foyda multiplikatori|CGTX (Cognition Therapeutics) - Forvard P/E multiplikatori|Forvard P/E multiplikatori inhibikase.com|Kelajakdagi narxning foydaga nisbati Cassava Sciences (SAVA)|ASRT: Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Prognoz qilingan narx-foyda nisbati|OVID: Prognoz qilingan narxning foydaga nisbati|ABOS - Forvard P/E multiplikatori|CRVO (CervoMed) - Prognoz qilingan narxning foydaga nisbati|ATHE: Kapitalizatsiyaning kelajakdagi foydaga nisbati|CLNN (Clene Inc) - Forvard P/E multiplikatori|PepGen Corp (PEPG) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori JUNS|Prognoz qilingan narxning foydaga nisbati relmada.com RLMD|Kelajakdagi narxning foydaga nisbati Annovis Bio ANVS|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Therapeutics Inc (GRCE)|Firefly Neuroscience Inc - Forvard P/E multiplikatori|Klotho Neurosciences Inc (KLTO) - Prognoz qilingan narxning foydaga nisbati|NRSN: Forvard P/E multiplikatori|revivapharma.com - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati MetaVia Inc.|NRXS: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Helius Medical (HSDT)|PASG - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Neuphoria Therapeutics NEUP|NERV: Narxning kelajakdagi foydaga nisbati|Athira Pharma - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Addex Therapeutics Ltd.|ALZN (alzamend.com) - Prognoz qilingan narxning foydaga nisbati|Cyclerion Therapeutics, Inc. (CYCN) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Protagenic Therapeutics Inc.|KTTA: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Cortigent, Inc. (CRGT)|ATXI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA - Prognoz qilingan narxning foydaga nisbati|Eliem - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori ITCI (Intra-Cellular Therapies)|Longboard Pharmaceuticals, Inc. (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus Pharmaceuticals Inc - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen|Prognoz qilingan narx-foyda nisbati NeuroBo Pharma NRBO|Kelajakdagi narxning foydaga nisbati Sage Therapeutics, Inc. (SAGE)|Prognoz qilingan narxning foydaga nisbati synaptogen.com SNPX|Kelajakdagi narxning foydaga nisbati Trevena TRVN|Vigil Neuroscience Inc. (VIGL) - Prognoz qilingan narx-foyda nisbati|Anew Medical - Forvard P/E multiplikatori|Cerevel Corp (CERE) - Prognoz qilingan narxning foydaga nisbati
